Mainstream

ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend

ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend

Post Contentrmd, rsmdfRead More

You might also be interested in reading Bitcoin Price Breaks Below $70K, Sellers Eye Further Downside.

August 1, 2025
In Mainstream